Abbott Diabetes Care Inc.

Other

Mark Kent Sloan

Gary Alan Hayter

Martin J Fennell

Daniel Milfred Bernstein

Michael R Love

Glenn Howard Berman

Lei He

Saeed Nekoomaram

Kenneth J Doniger

Marc Barry Taub

R Curtis Jennewine

Wesley Scott Harper

Jeffery Mario Sicurello

Phillip Yee

Timothy Christian Dunn

Jean-Pierre Cole

Annie C Tan

Nathan Christopher Crouther

Namvar Kiaie

Robert Y Jin

Erwin Satrya Budiman

Christopher V Reggiardo

Udo Hoss

Christopher Allen Thomas

Hyun Brian Cho

Theodore John Kunich

Charles W Wei

Charles T Liamos

Charles L Nelson

Feng Jiang

Arthur Eugene Anderson, Iii

Gary Ashley Stafford

Benjamin J Feldman

Louis G Pace

Geoffrey V McGarraugh

Xuandong Hua

Frederic Arbogast

Thomas Arnold Peyser

Tianmei Ouyang

Lam Tran

Royce Cheng

Gil Porat

Hung Dinh

Songbiao Zhang

Mani Gopal

David L Li

Jen-Chyun Chen

Mina Min Leung

Stephen Oja

Steve Scott

Jared Watkin

Jeffrey Mario Sicurello

Erich Yen

Douglas C Limbach

Jai Karan

Kurt E Leno

Christopher A Thomas

Jonathan M Fern

Ashwin Kumar

Mark P Jesser

William Matievich, Jr

Lynn Dixon

Matthew T Vogel

Benjamin Jay Feldman

Michael J Fullmer

Geoffrey V Mcgarraugh

Lynne K Lyons

John Dinh

Johnny Chang

Jessica Ching

Michael A Pani

Michael Pani

Curtis Jennewine

Jeffrey Sicurello

Martin J Fennel

Disclosed herein are methods and systems for conserving energy of a power source of an analyte monitoring device, including entering a power saving mode based on at least one of a temperature level of a power source, a level of power of a power source, or an amount of power needed by at least one component. Also disclosed herein are methods and systems for reducing noise during data transmissions to and from the analyte monitoring device.

Analyte monitoring system and methods for managing power and noise

Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.

Medical devices and methods

Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.

Displays for a medical device

Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.

Temperature-compensated analyte monitoring devices, systems, and methods thereof

Systems, devices, and methods are provided for the control of interfacing between applications that facilitate the monitoring of diabetes running on a mobile device, including the authentication of a third party user interface application by a sensor interface application. Control of the display of current analyte levels and critical events is also provided.

Application interface and display control in an analyte monitoring environment

Disclosed embodiments include methods and systems including a receiver unit of a glucose monitoring system. The receiver unit is configured to receive a key associated with a transmitter unit that enables the receiver unit to identify the transmitter unit, initiate communication with the transmitter unit, access a communication key uniquely associated with the transmitter unit, and receive communication packets from the remote transmitter unit on a periodic basis including data indicative of a glucose level of a bodily fluid. The receiver unit is further configured to process the data determine the glucose level for display, output a numerical representation of the determined glucose level in a GUI, and transmit data indicative of the glucose level to a second receiver unit.

Analyte monitoring system and methods

Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.

Continuous glucose monitoring system

Disclosed herein are methods and systems for receiving an encoded data packet, one or more activation commands, and a communication identifier, decoding the received data packet, validating the decoded received data packet, and executing one or more routines associated with the respective one or more activation commands.

Close proximity communication device and methods

Methods and systems for providing data communication in medical systems are disclosed.

Systems, devices, and methods are provided for the management of multiple sensor control devices and/or multiple reader devices in an in vivo analyte monitoring environment, and also for resolving conflicts when merging data collected by different reader devices.

Management of multiple devices within an analyte monitoring environment

Methods and devices for statistical determination of medication dosage level such as bolus amount based on contextual information are provided.

Method and system for providing contextual based medication dosage determination

Systems, devices and methods are provided that allow for enhanced performance, power efficiency, interoperability, data security and user privacy for in vivo analyte monitoring systems that utilize wireless communications. The in vivo analyte monitoring systems can include a Bluetooth or Bluetooth Low Energy enabled handheld relay device for wirelessly relaying analyte data between a sensor unit device and one or more reader devices. The in vivo analyte monitoring systems can employ advertisement and encryption schemes for wirelessly transmitting data in a manner that allows for improved security, efficiency and privacy.

Systems, devices, and methods for wireless communications in analyte monitoring systems

Growing community of inventors

Redwood City, CA, United States of America

Mark Kent Sloan